Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ahr
|
ENSMUSG00000019256.11 | aryl-hydrocarbon receptor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr12_35534289_35534927 | Ahr | 15 | 0.704653 | 0.62 | 5.2e-07 | Click! |
chr12_35534934_35535204 | Ahr | 31 | 0.926497 | 0.50 | 1.2e-04 | Click! |
chr12_35522834_35522985 | Ahr | 3870 | 0.209504 | -0.28 | 4.0e-02 | Click! |
chr12_35527242_35527441 | Ahr | 562 | 0.738755 | -0.27 | 4.5e-02 | Click! |
chr12_35538900_35539051 | Ahr | 3937 | 0.191607 | -0.15 | 2.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_151701768_151703133 | 35.26 |
Tmem74b |
transmembrane protein 74B |
139 |
0.92 |
chr10_78464271_78465733 | 34.47 |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
27 |
0.93 |
chr8_71670876_71671939 | 30.76 |
Unc13a |
unc-13 homolog A |
329 |
0.75 |
chr1_38835547_38836894 | 29.92 |
Lonrf2 |
LON peptidase N-terminal domain and ring finger 2 |
154 |
0.95 |
chr7_64697335_64697486 | 27.50 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
31992 |
0.2 |
chr9_89622321_89623673 | 27.33 |
Minar1 |
membrane integral NOTCH2 associated receptor 1 |
128 |
0.96 |
chr14_60176584_60177406 | 27.08 |
Atp8a2 |
ATPase, aminophospholipid transporter-like, class I, type 8A, member 2 |
544 |
0.71 |
chr6_91839426_91839831 | 27.03 |
Grip2 |
glutamate receptor interacting protein 2 |
12378 |
0.15 |
chr6_142964266_142965074 | 26.38 |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
218 |
0.91 |
chr9_124439906_124440949 | 25.15 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr17_55445850_55446443 | 23.85 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
98 |
0.98 |
chr13_51594988_51595203 | 23.28 |
Shc3 |
src homology 2 domain-containing transforming protein C3 |
25608 |
0.16 |
chr2_24761902_24762681 | 23.16 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
756 |
0.65 |
chr18_64265188_64265726 | 23.02 |
St8sia3 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 |
529 |
0.73 |
chr9_89909481_89910044 | 22.87 |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
146 |
0.97 |
chr5_45449714_45450578 | 22.85 |
Qdpr |
quinoid dihydropteridine reductase |
8 |
0.96 |
chr5_52115830_52115992 | 22.55 |
Gm43177 |
predicted gene 43177 |
1401 |
0.33 |
chr13_58807415_58808021 | 22.46 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
21 |
0.96 |
chr10_67912089_67912792 | 22.22 |
Zfp365 |
zinc finger protein 365 |
5 |
0.98 |
chr9_56635860_56636539 | 21.57 |
Lingo1 |
leucine rich repeat and Ig domain containing 1 |
571 |
0.77 |
chr10_32889642_32890523 | 20.79 |
Nkain2 |
Na+/K+ transporting ATPase interacting 2 |
234 |
0.95 |
chr10_81429712_81431957 | 20.71 |
Nfic |
nuclear factor I/C |
171 |
0.85 |
chr18_23309836_23310176 | 20.51 |
Gm7788 |
predicted gene 7788 |
93337 |
0.08 |
chr2_33130296_33131698 | 20.26 |
Garnl3 |
GTPase activating RANGAP domain-like 3 |
389 |
0.84 |
chr2_131040943_131041967 | 20.16 |
Gfra4 |
glial cell line derived neurotrophic factor family receptor alpha 4 |
2 |
0.94 |
chr5_37241363_37242150 | 19.99 |
Crmp1 |
collapsin response mediator protein 1 |
184 |
0.95 |
chr15_64311804_64313067 | 19.98 |
Asap1 |
ArfGAP with SH3 domain, ankyrin repeat and PH domain1 |
204 |
0.93 |
chr13_58806713_58806907 | 19.90 |
Ntrk2 |
neurotrophic tyrosine kinase, receptor, type 2 |
171 |
0.92 |
chr5_148398815_148400002 | 19.37 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
383 |
0.89 |
chr6_103512188_103512529 | 19.28 |
Chl1 |
cell adhesion molecule L1-like |
1028 |
0.51 |
chr2_24763086_24763581 | 19.19 |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
181 |
0.95 |
chr13_83722095_83722570 | 19.19 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
951 |
0.46 |
chr19_61225302_61226760 | 19.11 |
Csf2ra |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
541 |
0.67 |
chr12_29527021_29527799 | 18.40 |
Myt1l |
myelin transcription factor 1-like |
974 |
0.61 |
chr4_20777672_20778960 | 18.38 |
Nkain3 |
Na+/K+ transporting ATPase interacting 3 |
251 |
0.96 |
chr5_137286987_137287788 | 18.16 |
Ache |
acetylcholinesterase |
132 |
0.88 |
chr3_17793443_17793892 | 17.84 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
253 |
0.9 |
chr7_16134462_16134875 | 17.82 |
Slc8a2 |
solute carrier family 8 (sodium/calcium exchanger), member 2 |
4320 |
0.14 |
chr18_36017856_36019112 | 17.74 |
Nrg2 |
neuregulin 2 |
13457 |
0.16 |
chr2_180892991_180893395 | 17.43 |
Mir124a-3 |
microRNA 124a-3 |
847 |
0.31 |
chr3_80802510_80803270 | 17.38 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
55 |
0.98 |
chr8_71628994_71630252 | 17.01 |
Mir6769b |
microRNA 6769b |
1483 |
0.21 |
chr2_84887826_84888036 | 16.73 |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
1221 |
0.36 |
chr10_106469332_106470360 | 16.71 |
Ppfia2 |
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 |
493 |
0.82 |
chr4_19569392_19570378 | 16.71 |
Cpne3 |
copine III |
198 |
0.94 |
chr1_107481454_107481772 | 16.66 |
Serpinb2 |
serine (or cysteine) peptidase inhibitor, clade B, member 2 |
29810 |
0.14 |
chr3_8509423_8509607 | 16.62 |
Stmn2 |
stathmin-like 2 |
0 |
0.98 |
chr15_74487345_74487780 | 16.45 |
Adgrb1 |
adhesion G protein-coupled receptor B1 |
28633 |
0.16 |
chr10_87493217_87493966 | 16.34 |
Ascl1 |
achaete-scute family bHLH transcription factor 1 |
69 |
0.97 |
chr7_65527681_65527984 | 16.23 |
Tjp1 |
tight junction protein 1 |
51 |
0.98 |
chrX_6046872_6047632 | 16.17 |
Nudt11 |
nudix (nucleoside diphosphate linked moiety X)-type motif 11 |
201 |
0.92 |
chr5_66367756_66368075 | 16.14 |
Gm16273 |
predicted gene 16273 |
10997 |
0.14 |
chr13_83727309_83727854 | 15.99 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
525 |
0.66 |
chr18_6512985_6513158 | 15.93 |
Epc1 |
enhancer of polycomb homolog 1 |
3037 |
0.22 |
chr2_94273064_94274137 | 15.85 |
Mir670hg |
MIR670 host gene (non-protein coding) |
8682 |
0.15 |
chr8_15010942_15011363 | 15.80 |
Kbtbd11 |
kelch repeat and BTB (POZ) domain containing 11 |
127 |
0.93 |
chr2_181134637_181135435 | 15.65 |
Kcnq2 |
potassium voltage-gated channel, subfamily Q, member 2 |
91 |
0.95 |
chr4_91371091_91372260 | 15.62 |
Elavl2 |
ELAV like RNA binding protein 1 |
281 |
0.88 |
chrX_6091664_6091815 | 15.39 |
Gm26618 |
predicted gene, 26618 |
530 |
0.69 |
chr1_42684514_42684754 | 15.35 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
8459 |
0.14 |
chr11_7213273_7214485 | 15.20 |
Igfbp3 |
insulin-like growth factor binding protein 3 |
18 |
0.98 |
chr10_59089858_59090131 | 15.19 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
9960 |
0.24 |
chr15_26308516_26308700 | 15.15 |
Marchf11 |
membrane associated ring-CH-type finger 11 |
440 |
0.9 |
chr5_111724741_111725058 | 15.08 |
Gm26897 |
predicted gene, 26897 |
9025 |
0.18 |
chr12_3236518_3237725 | 15.07 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr1_84709939_84710116 | 15.02 |
Dner |
delta/notch-like EGF repeat containing |
13806 |
0.15 |
chr14_51358161_51358649 | 14.90 |
Gm7107 |
predicted gene 7107 |
198 |
0.86 |
chr14_45388403_45389548 | 14.86 |
Gnpnat1 |
glucosamine-phosphate N-acetyltransferase 1 |
14 |
0.96 |
chr19_36553934_36555231 | 14.81 |
Hectd2 |
HECT domain E3 ubiquitin protein ligase 2 |
57 |
0.98 |
chr4_116016940_116018214 | 14.67 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr12_116486150_116486505 | 14.56 |
Ptprn2 |
protein tyrosine phosphatase, receptor type, N polypeptide 2 |
494 |
0.73 |
chr13_14522874_14523297 | 14.47 |
Hecw1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
20 |
0.92 |
chr8_31089510_31090345 | 14.41 |
Dusp26 |
dual specificity phosphatase 26 (putative) |
123 |
0.96 |
chr5_116591724_116592384 | 14.35 |
Srrm4 |
serine/arginine repetitive matrix 4 |
237 |
0.93 |
chr19_42409134_42409463 | 14.20 |
Gm34299 |
predicted gene, 34299 |
1096 |
0.49 |
chr5_8622107_8622828 | 14.11 |
Rundc3b |
RUN domain containing 3B |
485 |
0.81 |
chr5_38158989_38159808 | 14.10 |
Nsg1 |
neuron specific gene family member 1 |
7 |
0.97 |
chr14_4110111_4111235 | 14.09 |
Gm8108 |
predicted gene 8108 |
147 |
0.94 |
chr4_17852942_17853620 | 14.03 |
Mmp16 |
matrix metallopeptidase 16 |
177 |
0.97 |
chr1_74858879_74859032 | 13.96 |
Cdk5r2 |
cyclin-dependent kinase 5, regulatory subunit 2 (p39) |
4021 |
0.13 |
chr7_40901519_40901801 | 13.93 |
A230077H06Rik |
RIKEN cDNA A230077H06 gene |
723 |
0.5 |
chr14_3948585_3949537 | 13.86 |
Gm3095 |
predicted gene 3095 |
14486 |
0.11 |
chr12_69908614_69908818 | 13.78 |
Atl1 |
atlastin GTPase 1 |
984 |
0.44 |
chr17_12769031_12770256 | 13.73 |
Igf2r |
insulin-like growth factor 2 receptor |
21 |
0.96 |
chr9_86879639_86880662 | 13.69 |
Snap91 |
synaptosomal-associated protein 91 |
247 |
0.94 |
chr14_12388940_12389425 | 13.66 |
Cadps |
Ca2+-dependent secretion activator |
11903 |
0.13 |
chr14_18893044_18894412 | 13.57 |
Ube2e2 |
ubiquitin-conjugating enzyme E2E 2 |
10 |
0.98 |
chr14_6037512_6038662 | 13.51 |
Gm8206 |
predicted gene 8206 |
122 |
0.93 |
chr14_25585435_25586044 | 13.49 |
Zmiz1 |
zinc finger, MIZ-type containing 1 |
21618 |
0.17 |
chr16_5767062_5767213 | 13.48 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
118218 |
0.06 |
chr12_29723997_29724347 | 13.47 |
C630031E19Rik |
RIKEN cDNA C630031E19 gene |
37727 |
0.21 |
chr4_154856178_154856666 | 13.47 |
Ttc34 |
tetratricopeptide repeat domain 34 |
222 |
0.91 |
chr15_95527932_95528173 | 13.46 |
Nell2 |
NEL-like 2 |
126 |
0.98 |
chr11_35798265_35798431 | 13.45 |
Fbll1 |
fibrillarin-like 1 |
536 |
0.71 |
chr3_65958052_65958719 | 13.38 |
Ccnl1 |
cyclin L1 |
136 |
0.85 |
chr18_16808514_16809103 | 13.38 |
Cdh2 |
cadherin 2 |
346 |
0.88 |
chr7_43488630_43488974 | 13.34 |
Iglon5 |
IgLON family member 5 |
1273 |
0.21 |
chr5_106926127_106926590 | 13.30 |
Hfm1 |
HFM1, ATP-dependent DNA helicase homolog |
37 |
0.97 |
chr2_22622362_22622693 | 13.22 |
Gad2 |
glutamic acid decarboxylase 2 |
322 |
0.84 |
chr6_61179832_61181181 | 13.19 |
Ccser1 |
coiled-coil serine rich 1 |
31 |
0.76 |
chr15_98792762_98792913 | 13.12 |
Wnt1 |
wingless-type MMTV integration site family, member 1 |
2980 |
0.12 |
chr14_61172444_61173564 | 13.05 |
Sacs |
sacsin |
14 |
0.98 |
chr7_4547209_4547689 | 12.94 |
Syt5 |
synaptotagmin V |
92 |
0.92 |
chr4_58911968_58912917 | 12.92 |
Ecpas |
Ecm29 proteasome adaptor and scaffold |
262 |
0.91 |
chr13_78194795_78195669 | 12.92 |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
1141 |
0.38 |
chr10_42864109_42864279 | 12.89 |
Gm34006 |
predicted gene, 34006 |
46 |
0.95 |
chr5_112481948_112482441 | 12.86 |
Sez6l |
seizure related 6 homolog like |
7067 |
0.17 |
chr14_4415827_4416278 | 12.83 |
Gm3164 |
predicted gene 3164 |
604 |
0.63 |
chr7_5057072_5057297 | 12.77 |
Ccdc106 |
coiled-coil domain containing 106 |
13 |
0.52 |
chr14_3572445_3572748 | 12.75 |
Gm3005 |
predicted gene 3005 |
573 |
0.69 |
chr8_40634456_40635069 | 12.70 |
Mtmr7 |
myotubularin related protein 7 |
3 |
0.98 |
chr13_42709847_42710338 | 12.58 |
Phactr1 |
phosphatase and actin regulator 1 |
511 |
0.85 |
chr6_48629216_48629950 | 12.57 |
AI854703 |
expressed sequence AI854703 |
1648 |
0.16 |
chr3_32616403_32617072 | 12.56 |
Gnb4 |
guanine nucleotide binding protein (G protein), beta 4 |
152 |
0.95 |
chr10_77032312_77033332 | 12.55 |
Slc19a1 |
solute carrier family 19 (folate transporter), member 1 |
138 |
0.94 |
chr5_120408930_120409318 | 12.55 |
Lhx5 |
LIM homeobox protein 5 |
22575 |
0.12 |
chr11_118569825_118570019 | 12.54 |
Rbfox3 |
RNA binding protein, fox-1 homolog (C. elegans) 3 |
12 |
0.98 |
chr1_18058368_18058994 | 12.50 |
Gm28756 |
predicted gene 28756 |
109 |
0.82 |
chr3_156560833_156561074 | 12.47 |
4930570G19Rik |
RIKEN cDNA 4930570G19 gene |
629 |
0.54 |
chr15_34678263_34678977 | 12.44 |
Nipal2 |
NIPA-like domain containing 2 |
84 |
0.97 |
chr7_60450080_60450452 | 12.41 |
Gm30196 |
predicted gene, 30196 |
157062 |
0.03 |
chr12_98573417_98573836 | 12.33 |
Kcnk10 |
potassium channel, subfamily K, member 10 |
1086 |
0.43 |
chr17_46454192_46454362 | 12.32 |
Gm5093 |
predicted gene 5093 |
14180 |
0.09 |
chr5_24423517_24424454 | 12.24 |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
126 |
0.78 |
chr11_57583351_57583694 | 12.20 |
Gm12243 |
predicted gene 12243 |
11010 |
0.18 |
chr17_13759899_13761731 | 12.18 |
Afdn |
afadin, adherens junction formation factor |
141 |
0.73 |
chr5_98180681_98181156 | 12.14 |
Prdm8 |
PR domain containing 8 |
60 |
0.97 |
chr7_45460493_45461322 | 12.12 |
Ftl1 |
ferritin light polypeptide 1 |
1023 |
0.19 |
chr15_84105394_84105979 | 12.05 |
Sult4a1 |
sulfotransferase family 4A, member 1 |
68 |
0.93 |
chr6_110645082_110646220 | 12.04 |
Grm7 |
glutamate receptor, metabotropic 7 |
69 |
0.76 |
chr10_81643079_81643993 | 11.99 |
Ankrd24 |
ankyrin repeat domain 24 |
267 |
0.8 |
chr13_12105853_12107098 | 11.99 |
Ryr2 |
ryanodine receptor 2, cardiac |
16 |
0.98 |
chrX_20060430_20060724 | 11.97 |
Chst7 |
carbohydrate (N-acetylglucosamino) sulfotransferase 7 |
1017 |
0.65 |
chr3_65529600_65529751 | 11.92 |
4931440P22Rik |
RIKEN cDNA 4931440P22 gene |
296 |
0.8 |
chr3_80800657_80801686 | 11.90 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
1408 |
0.52 |
chr4_148151043_148152234 | 11.89 |
Fbxo6 |
F-box protein 6 |
8 |
0.95 |
chr3_123266883_123267457 | 11.86 |
Sec24d |
Sec24 related gene family, member D (S. cerevisiae) |
285 |
0.9 |
chr6_129533069_129533908 | 11.84 |
Gabarapl1 |
gamma-aminobutyric acid (GABA) A receptor-associated protein-like 1 |
63 |
0.68 |
chr13_96130906_96131482 | 11.78 |
Sv2c |
synaptic vesicle glycoprotein 2c |
1383 |
0.35 |
chr9_78448347_78448872 | 11.78 |
Gm17324 |
predicted gene, 17324 |
177 |
0.7 |
chr8_75212715_75213244 | 11.71 |
Rasd2 |
RASD family, member 2 |
965 |
0.51 |
chr2_79456556_79457006 | 11.68 |
Cerkl |
ceramide kinase-like |
4 |
0.51 |
chr12_104617216_104617397 | 11.66 |
Dicer1 |
dicer 1, ribonuclease type III |
83196 |
0.07 |
chr7_44336781_44337350 | 11.66 |
Shank1 |
SH3 and multiple ankyrin repeat domains 1 |
1049 |
0.26 |
chr7_60216816_60216998 | 11.61 |
Gm18129 |
predicted gene, 18129 |
55953 |
0.08 |
chr18_67464673_67465310 | 11.60 |
Prelid3a |
PRELI domain containing 3A |
100 |
0.95 |
chr18_88040444_88040637 | 11.56 |
Gm50391 |
predicted gene, 50391 |
56010 |
0.16 |
chr12_102468744_102469733 | 11.55 |
Golga5 |
golgi autoantigen, golgin subfamily a, 5 |
46 |
0.97 |
chr8_17534538_17535388 | 11.52 |
Csmd1 |
CUB and Sushi multiple domains 1 |
318 |
0.95 |
chr8_15011823_15012201 | 11.50 |
Kbtbd11 |
kelch repeat and BTB (POZ) domain containing 11 |
706 |
0.52 |
chr13_88823587_88823949 | 11.44 |
Edil3 |
EGF-like repeats and discoidin I-like domains 3 |
2126 |
0.48 |
chr1_63445869_63446575 | 11.43 |
Adam23 |
a disintegrin and metallopeptidase domain 23 |
11 |
0.98 |
chr1_12992137_12992597 | 11.41 |
Slco5a1 |
solute carrier organic anion transporter family, member 5A1 |
283 |
0.92 |
chr13_36734718_36735494 | 11.38 |
Nrn1 |
neuritin 1 |
25 |
0.97 |
chr2_119873204_119873534 | 11.34 |
Gm13998 |
predicted gene 13998 |
5034 |
0.17 |
chr8_70315603_70316677 | 11.31 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr5_117241969_117242125 | 11.30 |
Taok3 |
TAO kinase 3 |
1587 |
0.31 |
chr16_31428916_31429697 | 11.30 |
Bdh1 |
3-hydroxybutyrate dehydrogenase, type 1 |
7 |
0.89 |
chr6_72958015_72959038 | 11.27 |
Tmsb10 |
thymosin, beta 10 |
38 |
0.97 |
chr9_50728353_50728545 | 11.25 |
Dixdc1 |
DIX domain containing 1 |
382 |
0.77 |
chr13_9277338_9277548 | 11.20 |
Dip2c |
disco interacting protein 2 homolog C |
461 |
0.73 |
chr1_5916552_5916955 | 11.15 |
Npbwr1 |
neuropeptides B/W receptor 1 |
645 |
0.81 |
chr4_25799474_25800254 | 11.14 |
Fut9 |
fucosyltransferase 9 |
9 |
0.98 |
chr7_107370275_107370871 | 11.12 |
Syt9 |
synaptotagmin IX |
155 |
0.95 |
chr13_30659801_30660671 | 11.11 |
Dusp22 |
dual specificity phosphatase 22 |
135 |
0.97 |
chr10_79874050_79875052 | 11.10 |
Plppr3 |
phospholipid phosphatase related 3 |
19 |
0.53 |
chr14_7173812_7174215 | 11.07 |
Gm3512 |
predicted gene 3512 |
520 |
0.73 |
chr14_13284178_13284565 | 11.06 |
Gm5087 |
predicted gene 5087 |
259 |
0.65 |
chr12_112928459_112928679 | 10.99 |
Jag2 |
jagged 2 |
121 |
0.92 |
chr8_83900764_83901270 | 10.98 |
Adgrl1 |
adhesion G protein-coupled receptor L1 |
282 |
0.85 |
chr1_132741692_132741971 | 10.98 |
Nfasc |
neurofascin |
34 |
0.98 |
chr13_54687539_54688580 | 10.97 |
Rnf44 |
ring finger protein 44 |
35 |
0.96 |
chr4_109977849_109978740 | 10.94 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
241 |
0.73 |
chr7_48959246_48959717 | 10.94 |
Nav2 |
neuron navigator 2 |
384 |
0.84 |
chr10_121739461_121740067 | 10.93 |
BC048403 |
cDNA sequence BC048403 |
173 |
0.95 |
chr3_13472740_13473374 | 10.90 |
Ralyl |
RALY RNA binding protein-like |
163 |
0.93 |
chr12_118846611_118847092 | 10.85 |
Sp8 |
trans-acting transcription factor 8 |
522 |
0.82 |
chr8_69881614_69881860 | 10.85 |
Cilp2 |
cartilage intermediate layer protein 2 |
5950 |
0.11 |
chr8_48555401_48556176 | 10.84 |
Tenm3 |
teneurin transmembrane protein 3 |
58 |
0.99 |
chr7_19118025_19118835 | 10.84 |
Gm4969 |
predicted gene 4969 |
62 |
0.92 |
chr15_103503595_103504009 | 10.80 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
525 |
0.71 |
chr3_127632944_127633268 | 10.79 |
Neurog2 |
neurogenin 2 |
29 |
0.96 |
chr1_39576504_39577731 | 10.75 |
Rnf149 |
ring finger protein 149 |
186 |
0.9 |
chr11_74590019_74590518 | 10.73 |
Rap1gap2 |
RAP1 GTPase activating protein 2 |
82 |
0.97 |
chrX_140278501_140278670 | 10.73 |
Gm15046 |
predicted gene 15046 |
723 |
0.71 |
chr9_99994460_99994673 | 10.72 |
4930519F24Rik |
RIKEN cDNA 4930519F24 gene |
27734 |
0.17 |
chr7_60140188_60140339 | 10.70 |
Snrpn |
small nuclear ribonucleoprotein N |
44 |
0.96 |
chr4_71483702_71483853 | 10.70 |
Rps18-ps1 |
ribosomal protein S18, pseudogene 1 |
112581 |
0.07 |
chr9_10904618_10904989 | 10.68 |
Cntn5 |
contactin 5 |
28 |
0.89 |
chr17_37196864_37197525 | 10.68 |
Olfr94 |
olfactory receptor 94 |
817 |
0.32 |
chr7_24316125_24316983 | 10.61 |
Zfp94 |
zinc finger protein 94 |
28 |
0.92 |
chr19_28834751_28835188 | 10.60 |
Slc1a1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
80 |
0.97 |
chr5_30712274_30713396 | 10.60 |
Dpysl5 |
dihydropyrimidinase-like 5 |
934 |
0.49 |
chr8_92460202_92460449 | 10.58 |
Gm45336 |
predicted gene 45336 |
5442 |
0.27 |
chr2_82053234_82053891 | 10.56 |
Zfp804a |
zinc finger protein 804A |
340 |
0.93 |
chr5_14514560_14515558 | 10.53 |
Pclo |
piccolo (presynaptic cytomatrix protein) |
66 |
0.97 |
chr17_66479375_66479588 | 10.51 |
Rab12 |
RAB12, member RAS oncogene family |
20838 |
0.14 |
chr4_154855718_154856156 | 10.46 |
Ttc34 |
tetratricopeptide repeat domain 34 |
263 |
0.89 |
chr8_47345782_47346002 | 10.46 |
Stox2 |
storkhead box 2 |
6456 |
0.26 |
chr11_35798556_35798728 | 10.44 |
Fbll1 |
fibrillarin-like 1 |
242 |
0.9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.9 | 41.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
13.3 | 39.8 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
11.7 | 58.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
8.9 | 35.7 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
8.0 | 23.9 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
7.6 | 30.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
7.4 | 22.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
7.2 | 28.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
7.1 | 14.3 | GO:0001661 | conditioned taste aversion(GO:0001661) |
7.1 | 21.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
7.0 | 7.0 | GO:0021586 | pons maturation(GO:0021586) |
6.6 | 26.4 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
6.5 | 19.5 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
6.2 | 18.5 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
6.1 | 18.3 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
6.0 | 18.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
5.9 | 17.8 | GO:0046959 | habituation(GO:0046959) |
5.9 | 17.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
5.9 | 82.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
5.9 | 17.6 | GO:0097503 | sialylation(GO:0097503) |
5.8 | 17.5 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
5.8 | 17.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
5.5 | 66.3 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
5.4 | 16.1 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
5.3 | 26.7 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
5.3 | 5.3 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
5.2 | 10.5 | GO:0071873 | response to norepinephrine(GO:0071873) |
5.2 | 20.8 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
5.2 | 20.8 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
5.1 | 41.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
5.1 | 15.4 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
5.0 | 10.0 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
5.0 | 34.9 | GO:0097264 | self proteolysis(GO:0097264) |
4.8 | 14.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
4.7 | 33.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
4.6 | 9.2 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
4.6 | 18.4 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
4.6 | 36.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
4.6 | 13.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
4.5 | 18.1 | GO:0006538 | glutamate catabolic process(GO:0006538) |
4.5 | 13.5 | GO:0021564 | vagus nerve development(GO:0021564) |
4.5 | 13.5 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
4.4 | 17.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
4.3 | 39.1 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
4.2 | 21.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
4.2 | 12.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
4.1 | 4.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
4.1 | 4.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
4.1 | 8.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
4.0 | 48.5 | GO:0048268 | clathrin coat assembly(GO:0048268) |
4.0 | 12.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
4.0 | 16.0 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
4.0 | 20.0 | GO:0098598 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
4.0 | 11.9 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
3.9 | 7.8 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
3.9 | 7.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
3.8 | 15.4 | GO:0090427 | activation of meiosis(GO:0090427) |
3.7 | 11.0 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
3.7 | 11.0 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
3.7 | 11.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
3.7 | 18.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
3.6 | 7.3 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
3.6 | 10.7 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
3.6 | 7.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
3.6 | 10.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
3.5 | 7.1 | GO:1901656 | glycoside transport(GO:1901656) |
3.4 | 16.8 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
3.3 | 9.8 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
3.3 | 3.3 | GO:0090135 | actin filament branching(GO:0090135) |
3.2 | 29.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
3.2 | 29.2 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
3.2 | 16.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.2 | 9.5 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
3.2 | 3.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
3.2 | 15.8 | GO:0019695 | choline metabolic process(GO:0019695) |
3.2 | 6.3 | GO:1904023 | regulation of fermentation(GO:0043465) regulation of NAD metabolic process(GO:1902688) regulation of glucose catabolic process to lactate via pyruvate(GO:1904023) |
3.1 | 6.3 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
3.1 | 9.3 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
3.1 | 24.8 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
3.1 | 3.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
3.1 | 3.1 | GO:0043133 | hindgut contraction(GO:0043133) regulation of hindgut contraction(GO:0043134) |
3.0 | 12.2 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
3.0 | 12.2 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
3.0 | 18.2 | GO:0016198 | axon choice point recognition(GO:0016198) |
3.0 | 21.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
3.0 | 3.0 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
3.0 | 35.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
3.0 | 3.0 | GO:1990035 | calcium ion import into cell(GO:1990035) |
2.9 | 5.9 | GO:0007412 | axon target recognition(GO:0007412) |
2.9 | 8.8 | GO:0001927 | exocyst assembly(GO:0001927) |
2.9 | 14.4 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
2.9 | 5.7 | GO:0060594 | mammary gland specification(GO:0060594) |
2.9 | 8.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
2.9 | 8.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.8 | 8.5 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
2.8 | 8.5 | GO:0021825 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) substrate-dependent cerebral cortex tangential migration(GO:0021825) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
2.8 | 11.2 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
2.8 | 19.6 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
2.8 | 8.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
2.8 | 11.1 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
2.7 | 18.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.7 | 5.4 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
2.7 | 8.0 | GO:0060437 | lung growth(GO:0060437) |
2.7 | 8.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.6 | 5.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.6 | 13.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.6 | 2.6 | GO:0061183 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
2.6 | 2.6 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.6 | 10.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
2.6 | 2.6 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
2.6 | 7.7 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
2.5 | 10.2 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
2.5 | 5.0 | GO:0099612 | protein localization to axon(GO:0099612) |
2.5 | 7.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
2.5 | 7.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
2.5 | 7.4 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
2.5 | 14.9 | GO:0015884 | folic acid transport(GO:0015884) |
2.5 | 4.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
2.5 | 2.5 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
2.5 | 9.8 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
2.4 | 7.3 | GO:0030070 | insulin processing(GO:0030070) |
2.4 | 7.3 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
2.4 | 7.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
2.4 | 12.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
2.4 | 7.2 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
2.4 | 9.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
2.4 | 45.5 | GO:0001964 | startle response(GO:0001964) |
2.4 | 7.2 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
2.4 | 45.1 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.4 | 7.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
2.4 | 7.1 | GO:0046084 | adenine metabolic process(GO:0046083) adenine biosynthetic process(GO:0046084) |
2.4 | 7.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
2.3 | 7.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
2.3 | 7.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.3 | 9.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
2.3 | 23.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
2.3 | 16.2 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
2.3 | 4.6 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
2.3 | 4.6 | GO:0048880 | sensory system development(GO:0048880) |
2.3 | 4.6 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
2.3 | 2.3 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
2.3 | 6.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.3 | 15.8 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
2.3 | 6.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
2.2 | 6.7 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
2.2 | 4.5 | GO:0060174 | limb bud formation(GO:0060174) |
2.2 | 9.0 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
2.2 | 6.7 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.2 | 8.9 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
2.2 | 4.4 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
2.2 | 11.0 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
2.2 | 2.2 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
2.2 | 6.6 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
2.2 | 6.6 | GO:0061511 | centriole elongation(GO:0061511) |
2.2 | 8.7 | GO:0030035 | microspike assembly(GO:0030035) |
2.2 | 8.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
2.2 | 6.5 | GO:0030916 | otic vesicle formation(GO:0030916) |
2.1 | 4.3 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
2.1 | 6.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
2.1 | 4.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
2.1 | 4.2 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
2.1 | 10.4 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
2.1 | 16.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
2.1 | 6.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
2.1 | 4.1 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
2.0 | 4.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
2.0 | 8.2 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
2.0 | 22.1 | GO:0036065 | fucosylation(GO:0036065) |
2.0 | 6.0 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
2.0 | 6.0 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
2.0 | 2.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
2.0 | 13.8 | GO:0006983 | ER overload response(GO:0006983) |
2.0 | 7.9 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
2.0 | 15.7 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
2.0 | 5.9 | GO:0008355 | olfactory learning(GO:0008355) |
2.0 | 2.0 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.9 | 1.9 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
1.9 | 3.9 | GO:0015888 | thiamine transport(GO:0015888) |
1.9 | 1.9 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
1.9 | 62.1 | GO:0019228 | neuronal action potential(GO:0019228) |
1.9 | 3.9 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
1.9 | 5.8 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
1.9 | 13.5 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
1.9 | 9.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
1.9 | 11.6 | GO:0071625 | vocalization behavior(GO:0071625) |
1.9 | 15.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
1.9 | 15.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.9 | 7.6 | GO:0021978 | telencephalon regionalization(GO:0021978) |
1.9 | 9.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.9 | 7.5 | GO:0008038 | neuron recognition(GO:0008038) |
1.9 | 5.6 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.8 | 3.7 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.8 | 27.6 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
1.8 | 1.8 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.8 | 7.3 | GO:0015816 | glycine transport(GO:0015816) |
1.8 | 5.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.8 | 7.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.8 | 5.4 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.8 | 10.8 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.8 | 7.2 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
1.8 | 3.6 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
1.8 | 7.2 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
1.8 | 8.9 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.8 | 3.6 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
1.8 | 3.6 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
1.8 | 1.8 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
1.8 | 5.3 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
1.8 | 3.5 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
1.7 | 97.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
1.7 | 5.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
1.7 | 5.2 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
1.7 | 3.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.7 | 6.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
1.7 | 3.5 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
1.7 | 3.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.7 | 1.7 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) cardiac muscle cell membrane repolarization(GO:0099622) regulation of cardiac muscle cell membrane repolarization(GO:0099623) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
1.7 | 5.1 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
1.7 | 15.4 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
1.7 | 1.7 | GO:0072289 | metanephric nephron tubule formation(GO:0072289) |
1.7 | 6.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.7 | 8.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.7 | 5.1 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
1.7 | 5.0 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
1.7 | 10.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.7 | 10.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
1.6 | 4.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
1.6 | 131.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
1.6 | 3.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
1.6 | 4.9 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
1.6 | 1.6 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
1.6 | 4.9 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
1.6 | 6.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
1.6 | 4.9 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
1.6 | 8.1 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
1.6 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
1.6 | 6.4 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.6 | 6.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
1.6 | 3.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.6 | 6.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.6 | 9.6 | GO:0021884 | forebrain neuron development(GO:0021884) |
1.6 | 3.2 | GO:0001880 | Mullerian duct regression(GO:0001880) |
1.6 | 25.5 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
1.6 | 9.6 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
1.6 | 4.8 | GO:0003150 | membranous septum morphogenesis(GO:0003149) muscular septum morphogenesis(GO:0003150) |
1.6 | 14.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.6 | 4.7 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
1.6 | 12.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
1.6 | 26.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
1.5 | 1.5 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
1.5 | 1.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
1.5 | 4.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.5 | 7.6 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.5 | 9.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
1.5 | 1.5 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
1.5 | 4.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
1.5 | 6.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
1.5 | 4.5 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.5 | 4.5 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.5 | 31.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
1.5 | 3.0 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
1.5 | 10.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.5 | 4.4 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
1.5 | 2.9 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
1.5 | 4.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.4 | 5.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
1.4 | 1.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
1.4 | 5.8 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.4 | 4.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
1.4 | 4.3 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
1.4 | 4.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.4 | 7.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.4 | 11.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
1.4 | 4.2 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.4 | 4.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
1.4 | 2.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.4 | 4.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.4 | 4.2 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.4 | 13.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
1.4 | 1.4 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.4 | 5.5 | GO:0051013 | microtubule severing(GO:0051013) |
1.4 | 4.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
1.4 | 1.4 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
1.4 | 2.7 | GO:0002840 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
1.4 | 4.1 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.4 | 5.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.3 | 5.4 | GO:2000667 | interleukin-5 secretion(GO:0072603) interleukin-13 secretion(GO:0072611) regulation of interleukin-5 secretion(GO:2000662) positive regulation of interleukin-5 secretion(GO:2000664) regulation of interleukin-13 secretion(GO:2000665) positive regulation of interleukin-13 secretion(GO:2000667) |
1.3 | 5.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.3 | 2.7 | GO:0036394 | amylase secretion(GO:0036394) |
1.3 | 4.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.3 | 4.0 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
1.3 | 1.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
1.3 | 6.6 | GO:0021854 | hypothalamus development(GO:0021854) |
1.3 | 5.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
1.3 | 18.2 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.3 | 3.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.3 | 5.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
1.3 | 7.7 | GO:0031000 | response to caffeine(GO:0031000) |
1.3 | 1.3 | GO:0030421 | defecation(GO:0030421) |
1.3 | 25.5 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
1.3 | 3.8 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
1.3 | 1.3 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.3 | 5.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
1.3 | 3.8 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
1.3 | 1.3 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
1.3 | 2.5 | GO:0032898 | neurotrophin production(GO:0032898) |
1.3 | 5.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
1.3 | 3.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
1.3 | 2.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
1.3 | 1.3 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
1.3 | 3.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.2 | 5.0 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
1.2 | 1.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
1.2 | 2.5 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
1.2 | 6.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
1.2 | 1.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
1.2 | 2.4 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
1.2 | 3.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.2 | 6.1 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
1.2 | 3.6 | GO:0015705 | iodide transport(GO:0015705) |
1.2 | 6.0 | GO:0051775 | response to redox state(GO:0051775) |
1.2 | 3.6 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.2 | 3.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
1.2 | 9.6 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
1.2 | 31.3 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
1.2 | 4.8 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.2 | 6.0 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.2 | 4.8 | GO:0033762 | response to glucagon(GO:0033762) |
1.2 | 3.6 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
1.2 | 4.8 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
1.2 | 7.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
1.2 | 2.4 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.2 | 11.7 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) |
1.2 | 5.9 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
1.2 | 2.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.2 | 4.7 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.2 | 7.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.2 | 17.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
1.2 | 8.1 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
1.2 | 1.2 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
1.1 | 2.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
1.1 | 1.1 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
1.1 | 3.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.1 | 2.3 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.1 | 6.8 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
1.1 | 4.6 | GO:0086026 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
1.1 | 4.6 | GO:0021871 | forebrain regionalization(GO:0021871) |
1.1 | 9.1 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
1.1 | 2.3 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
1.1 | 2.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
1.1 | 4.5 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
1.1 | 2.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.1 | 2.2 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
1.1 | 3.4 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.1 | 2.2 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
1.1 | 9.9 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
1.1 | 4.4 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
1.1 | 8.8 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
1.1 | 2.2 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
1.1 | 1.1 | GO:1990123 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.1 | 3.3 | GO:0051182 | coenzyme transport(GO:0051182) |
1.1 | 4.4 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
1.1 | 5.4 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.1 | 1.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
1.1 | 3.2 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
1.1 | 8.7 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
1.1 | 3.2 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
1.1 | 2.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.1 | 2.1 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.1 | 3.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.1 | 1.1 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.1 | 9.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.1 | 5.3 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
1.1 | 2.1 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.1 | 9.5 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
1.0 | 3.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
1.0 | 4.2 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
1.0 | 5.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.0 | 1.0 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
1.0 | 4.2 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.0 | 3.1 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
1.0 | 4.1 | GO:0006598 | polyamine catabolic process(GO:0006598) |
1.0 | 3.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
1.0 | 1.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.0 | 4.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.0 | 3.1 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
1.0 | 2.0 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.0 | 3.1 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.0 | 2.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.0 | 4.1 | GO:0016078 | tRNA catabolic process(GO:0016078) |
1.0 | 2.0 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.0 | 5.0 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
1.0 | 4.0 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
1.0 | 1.0 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
1.0 | 6.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
1.0 | 3.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
1.0 | 3.0 | GO:0008354 | germ cell migration(GO:0008354) |
1.0 | 2.0 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
1.0 | 1.0 | GO:0060155 | platelet dense granule organization(GO:0060155) |
1.0 | 1.9 | GO:0017085 | response to insecticide(GO:0017085) |
1.0 | 1.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
1.0 | 4.8 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
1.0 | 1.9 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
1.0 | 13.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.0 | 3.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.0 | 4.8 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.0 | 1.9 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
1.0 | 3.8 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
1.0 | 4.8 | GO:0035493 | SNARE complex assembly(GO:0035493) |
1.0 | 1.9 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.9 | 1.9 | GO:0060825 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.9 | 0.9 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.9 | 7.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.9 | 1.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.9 | 2.8 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.9 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.9 | 6.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.9 | 2.8 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.9 | 26.3 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.9 | 4.7 | GO:0090383 | phagosome acidification(GO:0090383) |
0.9 | 6.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.9 | 2.8 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.9 | 2.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.9 | 5.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.9 | 9.3 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.9 | 32.5 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.9 | 4.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.9 | 7.4 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.9 | 3.7 | GO:1900094 | nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
0.9 | 2.8 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.9 | 1.8 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.9 | 1.8 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.9 | 1.8 | GO:0034633 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.9 | 1.8 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.9 | 7.3 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.9 | 4.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.9 | 2.7 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.9 | 5.5 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.9 | 4.5 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.9 | 1.8 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.9 | 1.8 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
0.9 | 1.8 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.9 | 5.4 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.9 | 2.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.9 | 1.8 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.9 | 3.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.9 | 0.9 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
0.9 | 1.8 | GO:0060013 | righting reflex(GO:0060013) |
0.9 | 2.7 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.9 | 3.6 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.9 | 4.4 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.9 | 0.9 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.9 | 8.9 | GO:0034331 | cell junction maintenance(GO:0034331) |
0.9 | 4.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.9 | 25.4 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.9 | 2.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.9 | 1.7 | GO:1902744 | negative regulation of lamellipodium organization(GO:1902744) |
0.9 | 3.4 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.9 | 6.0 | GO:0060736 | prostate gland growth(GO:0060736) |
0.9 | 21.3 | GO:0034605 | cellular response to heat(GO:0034605) |
0.8 | 2.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.8 | 2.5 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.8 | 2.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.8 | 1.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.8 | 5.1 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.8 | 2.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.8 | 1.7 | GO:2000674 | regulation of type B pancreatic cell apoptotic process(GO:2000674) negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.8 | 2.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.8 | 1.7 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.8 | 2.5 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.8 | 1.7 | GO:0048296 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.8 | 1.7 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.8 | 2.5 | GO:0030432 | peristalsis(GO:0030432) |
0.8 | 1.7 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.8 | 4.9 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.8 | 4.9 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.8 | 2.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.8 | 5.7 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.8 | 2.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.8 | 1.6 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.8 | 0.8 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.8 | 3.2 | GO:0035627 | ceramide transport(GO:0035627) |
0.8 | 2.4 | GO:0002934 | desmosome organization(GO:0002934) |
0.8 | 4.8 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.8 | 6.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.8 | 4.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.8 | 2.4 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.8 | 2.3 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.8 | 1.5 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.8 | 3.1 | GO:1900113 | regulation of histone H3-K9 trimethylation(GO:1900112) negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.8 | 0.8 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.8 | 3.1 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.8 | 4.6 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.8 | 73.6 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.8 | 3.8 | GO:0010560 | positive regulation of glycoprotein biosynthetic process(GO:0010560) |
0.8 | 5.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.8 | 3.0 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.7 | 3.0 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
0.7 | 5.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.7 | 10.4 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.7 | 3.0 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
0.7 | 8.8 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.7 | 2.9 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.7 | 2.2 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.7 | 2.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.7 | 1.4 | GO:0009629 | response to gravity(GO:0009629) |
0.7 | 3.6 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.7 | 1.4 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.7 | 2.1 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.7 | 2.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.7 | 0.7 | GO:1903423 | regulation of synaptic vesicle recycling(GO:1903421) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.7 | 1.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.7 | 2.8 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.7 | 2.8 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.7 | 3.5 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.7 | 1.4 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.7 | 4.2 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.7 | 1.4 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.7 | 1.4 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.7 | 2.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.7 | 2.8 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.7 | 3.5 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.7 | 2.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.7 | 4.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.7 | 2.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.7 | 0.7 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.7 | 3.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.7 | 6.9 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.7 | 4.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.7 | 2.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.7 | 2.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 2.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.7 | 1.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.7 | 2.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.7 | 3.4 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.7 | 2.7 | GO:0042637 | catagen(GO:0042637) |
0.7 | 0.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.7 | 2.7 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.7 | 4.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.7 | 1.3 | GO:0032252 | secretory granule localization(GO:0032252) |
0.7 | 1.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.7 | 4.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.7 | 2.7 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.7 | 3.3 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.7 | 2.0 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 2.6 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.7 | 2.6 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.7 | 4.6 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.6 | 1.9 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.6 | 3.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.6 | 0.6 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.6 | 1.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.6 | 1.3 | GO:0060004 | reflex(GO:0060004) |
0.6 | 7.6 | GO:0045056 | transcytosis(GO:0045056) |
0.6 | 0.6 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.6 | 6.3 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.6 | 1.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.6 | 2.5 | GO:0051697 | protein delipidation(GO:0051697) |
0.6 | 2.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.6 | 33.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.6 | 4.4 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.6 | 3.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.6 | 0.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 5.6 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.6 | 1.2 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.6 | 6.1 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.6 | 2.4 | GO:0048069 | eye pigmentation(GO:0048069) |
0.6 | 1.2 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.6 | 2.4 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.6 | 4.2 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.6 | 1.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.6 | 7.8 | GO:0007416 | synapse assembly(GO:0007416) |
0.6 | 0.6 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.6 | 9.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
0.6 | 1.8 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.6 | 3.0 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.6 | 2.4 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.6 | 1.2 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.6 | 1.2 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.6 | 2.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.6 | 4.7 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 0.6 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.6 | 1.2 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.6 | 4.1 | GO:0031103 | axon regeneration(GO:0031103) |
0.6 | 1.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.6 | 1.1 | GO:0061743 | motor learning(GO:0061743) |
0.6 | 1.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.6 | 2.9 | GO:0060539 | diaphragm development(GO:0060539) |
0.6 | 15.4 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
0.6 | 4.6 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.6 | 1.1 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.6 | 1.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.6 | 0.6 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.6 | 1.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.6 | 1.1 | GO:0031296 | B cell costimulation(GO:0031296) |
0.6 | 0.6 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) positive regulation of tooth mineralization(GO:0070172) |
0.5 | 3.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.5 | 1.1 | GO:0060872 | semicircular canal development(GO:0060872) |
0.5 | 3.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.5 | 8.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 0.5 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.5 | 1.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.5 | 5.4 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.5 | 2.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.5 | 0.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.5 | 0.5 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.5 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.5 | 1.0 | GO:0030576 | Cajal body organization(GO:0030576) |
0.5 | 3.1 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.5 | 5.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.5 | 4.7 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.5 | 1.0 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.5 | 0.5 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.5 | 0.5 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 3.0 | GO:1905145 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.5 | 1.5 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 3.0 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.5 | 2.5 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.5 | 1.0 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 2.0 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 1.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 1.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 1.5 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.5 | 1.0 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.5 | 0.5 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.5 | 1.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.5 | 2.5 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.5 | 3.0 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.5 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.5 | 4.9 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.5 | 2.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.5 | 1.0 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.5 | 4.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.5 | 1.4 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.5 | 2.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 13.4 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.5 | 5.8 | GO:0031646 | positive regulation of neurological system process(GO:0031646) |
0.5 | 1.0 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.5 | 6.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.5 | 4.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.5 | 0.5 | GO:0060221 | retinal rod cell differentiation(GO:0060221) positive regulation of receptor clustering(GO:1903911) |
0.5 | 4.7 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 0.5 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.5 | 1.4 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 1.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.5 | 1.4 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.5 | 0.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.5 | 1.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.5 | 4.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.4 | 0.9 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.4 | 0.9 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.4 | 1.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 0.4 | GO:0003337 | mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) |
0.4 | 2.6 | GO:0051571 | positive regulation of histone H3-K4 methylation(GO:0051571) |
0.4 | 2.2 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.4 | 1.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.4 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 3.1 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.4 | 1.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.4 | 4.8 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.4 | 0.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.4 | 1.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.4 | 3.9 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.4 | 0.4 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.4 | 0.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.4 | 0.9 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.4 | 1.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.4 | 2.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.4 | 1.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.4 | 1.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.4 | 2.5 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.4 | 0.8 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.4 | 2.9 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.4 | 2.1 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.4 | 4.1 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
0.4 | 1.6 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.4 | 10.3 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.4 | 5.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 16.0 | GO:0007612 | learning(GO:0007612) |
0.4 | 6.1 | GO:0090102 | cochlea development(GO:0090102) |
0.4 | 0.8 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.4 | 12.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.4 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 0.4 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.4 | 1.2 | GO:0015867 | ATP transport(GO:0015867) |
0.4 | 1.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.4 | 1.6 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 0.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 2.4 | GO:0055062 | phosphate ion homeostasis(GO:0055062) cellular divalent inorganic anion homeostasis(GO:0072501) trivalent inorganic anion homeostasis(GO:0072506) |
0.4 | 0.4 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.4 | 0.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 3.5 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 0.4 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.4 | 8.1 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.4 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.4 | 0.8 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.4 | 4.2 | GO:0007041 | lysosomal transport(GO:0007041) |
0.4 | 7.6 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
0.4 | 1.1 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.4 | 0.8 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 0.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.4 | 1.9 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.4 | 2.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.4 | 0.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.4 | 0.4 | GO:0014028 | notochord formation(GO:0014028) |
0.4 | 0.7 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 4.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.4 | 1.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.4 | 0.4 | GO:0021544 | subpallium development(GO:0021544) |
0.4 | 2.1 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.3 | 3.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 2.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.3 | 5.2 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
0.3 | 0.3 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.3 | 2.8 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.3 | 1.0 | GO:0001555 | oocyte growth(GO:0001555) |
0.3 | 0.7 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.3 | 0.3 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.3 | 0.3 | GO:0014029 | neural crest formation(GO:0014029) |
0.3 | 1.4 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 1.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 2.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 0.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 1.0 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.3 | 11.1 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.3 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 11.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
0.3 | 1.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.3 | 0.3 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 1.6 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.3 | 0.6 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.3 | 1.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.3 | 1.6 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.3 | 0.3 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.3 | 1.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.3 | 1.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 1.6 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.3 | 0.6 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.3 | 0.3 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.3 | 1.2 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.3 | 1.2 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
0.3 | 4.0 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.3 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.3 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.3 | 0.6 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 0.3 | GO:2000412 | thymocyte migration(GO:0072679) regulation of thymocyte migration(GO:2000410) positive regulation of thymocyte migration(GO:2000412) |
0.3 | 0.3 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.3 | 0.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.3 | 1.5 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.3 | 0.9 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.3 | 0.3 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.3 | 0.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 0.6 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.3 | 0.3 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.3 | 1.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.3 | 0.6 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 3.8 | GO:0045954 | positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.3 | 7.5 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.3 | 2.0 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.3 | 0.3 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.3 | 1.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 1.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.3 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.3 | 0.6 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.3 | 0.8 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.3 | 0.3 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.3 | 0.8 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.3 | 2.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.3 | 1.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 1.1 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.3 | 0.5 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 0.5 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.3 | 9.3 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.3 | 0.3 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.3 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 9.5 | GO:0030804 | positive regulation of cyclic nucleotide biosynthetic process(GO:0030804) |
0.3 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 3.7 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.3 | 0.8 | GO:0000467 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.3 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.3 | 0.3 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.3 | 7.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.3 | 1.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 1.0 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.3 | 0.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.3 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.3 | 1.0 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 1.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 1.2 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.2 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.2 | GO:0090237 | regulation of icosanoid secretion(GO:0032303) regulation of arachidonic acid secretion(GO:0090237) |
0.2 | 2.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.2 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.2 | 1.2 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.2 | 0.5 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 4.9 | GO:0006813 | potassium ion transport(GO:0006813) |
0.2 | 0.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.5 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 1.4 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.2 | 0.9 | GO:0007320 | insemination(GO:0007320) |
0.2 | 1.6 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.2 | 1.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.2 | 0.7 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.7 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
0.2 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.2 | 1.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.2 | 1.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.7 | GO:0045076 | regulation of interleukin-2 biosynthetic process(GO:0045076) |
0.2 | 1.8 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.2 | 0.7 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 2.0 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.2 | 1.6 | GO:0007289 | spermatid nucleus differentiation(GO:0007289) |
0.2 | 0.9 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 11.8 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
0.2 | 0.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 6.9 | GO:0006400 | tRNA modification(GO:0006400) |
0.2 | 0.4 | GO:0045991 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) carbon catabolite activation of transcription(GO:0045991) |
0.2 | 0.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 1.1 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 | 0.2 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.2 | 0.6 | GO:0086065 | cell communication involved in cardiac conduction(GO:0086065) |
0.2 | 2.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 0.4 | GO:0002713 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.2 | 0.6 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.6 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 2.0 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.2 | 1.2 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 0.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.2 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) |
0.2 | 0.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.4 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.2 | 1.6 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.2 | 1.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.2 | 0.4 | GO:0002692 | negative regulation of cellular extravasation(GO:0002692) |
0.2 | 1.9 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 10.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.2 | 0.4 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.2 | 0.8 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.2 | 1.3 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.2 | 0.9 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 1.5 | GO:1902547 | regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902547) |
0.2 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 2.2 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.2 | 1.3 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.2 | 0.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 0.9 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.2 | 0.5 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 4.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.2 | 0.2 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.2 | 0.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.2 | 1.7 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.3 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.2 | 0.2 | GO:1990144 | intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
0.2 | 0.2 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 0.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.2 | 2.3 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.5 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.2 | 0.2 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.2 | 0.2 | GO:0070141 | response to UV-A(GO:0070141) |
0.2 | 0.8 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.3 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.2 | 2.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 0.3 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.2 | GO:0090148 | membrane fission(GO:0090148) |
0.2 | 0.2 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.2 | 0.6 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.2 | 0.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.2 | 0.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.2 | 0.2 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.2 | 0.3 | GO:0009137 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.1 | 0.3 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.1 | 0.7 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
0.1 | 0.3 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.1 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.1 | 0.3 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 0.4 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.3 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.1 | 0.5 | GO:0032402 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) |
0.1 | 0.1 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.1 | 0.5 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.3 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.1 | 1.2 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.3 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.7 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.1 | 0.2 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.2 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.1 | 0.5 | GO:0043328 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.1 | 3.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.2 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.1 | 0.1 | GO:0010751 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.3 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.4 | GO:0033198 | response to ATP(GO:0033198) |
0.1 | 1.7 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.1 | 1.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.2 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.2 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.1 | 1.0 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 1.1 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.3 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.1 | 0.4 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.2 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.4 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.1 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.1 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.1 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.1 | 0.5 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.1 | 0.1 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.1 | 0.3 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.1 | 0.2 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.1 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) |
0.1 | 0.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.3 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.1 | 0.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.2 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.1 | 0.3 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.1 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.2 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.3 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.1 | GO:1990874 | regulation of vascular smooth muscle cell proliferation(GO:1904705) vascular smooth muscle cell proliferation(GO:1990874) |
0.1 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 0.7 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.5 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 0.2 | GO:0009651 | response to salt stress(GO:0009651) |
0.1 | 0.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 0.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 0.1 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.1 | 0.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.4 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.3 | GO:0042517 | positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
0.1 | 0.1 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.1 | 0.2 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.1 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 0.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.1 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.2 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.7 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.2 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.0 | 0.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.0 | 0.4 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.0 | 1.9 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.0 | 0.3 | GO:0006582 | melanin metabolic process(GO:0006582) |
0.0 | 0.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.0 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.0 | 0.1 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 0.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.0 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.0 | 0.3 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.0 | 0.1 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.4 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.0 | GO:0061525 | hindgut development(GO:0061525) |
0.0 | 0.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.0 | 0.0 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.0 | 0.1 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.0 | 0.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.1 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.0 | 0.0 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
0.0 | 0.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.0 | GO:0044805 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.0 | 0.1 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.0 | 0.0 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.0 | 0.0 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.0 | 0.0 | GO:1901374 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.0 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.0 | 0.0 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 15.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0072505 | divalent inorganic anion homeostasis(GO:0072505) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.0 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.0 | GO:0042640 | anagen(GO:0042640) |
0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.0 | 0.0 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.6 | 8.6 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
7.3 | 29.1 | GO:0042567 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
6.8 | 20.5 | GO:0072534 | perineuronal net(GO:0072534) |
5.8 | 69.4 | GO:0043194 | axon initial segment(GO:0043194) |
5.8 | 28.8 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.7 | 22.7 | GO:0044316 | cone cell pedicle(GO:0044316) |
5.5 | 66.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
5.5 | 147.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
5.0 | 14.9 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
4.5 | 40.3 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
4.4 | 13.3 | GO:1990635 | proximal dendrite(GO:1990635) |
4.4 | 172.3 | GO:0042734 | presynaptic membrane(GO:0042734) |
4.3 | 21.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
4.2 | 58.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
4.1 | 8.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
4.1 | 16.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
3.9 | 7.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
3.7 | 11.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
3.2 | 6.5 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
3.0 | 41.7 | GO:0031045 | dense core granule(GO:0031045) |
2.9 | 2.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
2.9 | 8.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
2.7 | 2.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
2.7 | 10.8 | GO:0008091 | spectrin(GO:0008091) |
2.7 | 2.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
2.7 | 47.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
2.5 | 12.7 | GO:0000235 | astral microtubule(GO:0000235) |
2.5 | 7.4 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.5 | 9.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
2.5 | 7.4 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.4 | 38.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
2.4 | 65.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
2.3 | 6.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.2 | 8.9 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
2.2 | 4.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
2.2 | 13.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.1 | 19.3 | GO:0030673 | axolemma(GO:0030673) |
2.1 | 89.1 | GO:0043198 | dendritic shaft(GO:0043198) |
2.1 | 6.3 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
2.0 | 2.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.9 | 9.7 | GO:0043083 | synaptic cleft(GO:0043083) |
1.9 | 7.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
1.9 | 9.4 | GO:0097433 | dense body(GO:0097433) |
1.9 | 41.1 | GO:0044298 | cell body membrane(GO:0044298) |
1.9 | 11.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.8 | 5.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.8 | 9.2 | GO:0043203 | axon hillock(GO:0043203) |
1.8 | 12.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.8 | 5.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
1.8 | 8.9 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
1.7 | 17.5 | GO:0005687 | U4 snRNP(GO:0005687) |
1.7 | 5.1 | GO:0042583 | chromaffin granule(GO:0042583) |
1.6 | 41.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.6 | 81.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.6 | 4.9 | GO:0033010 | paranodal junction(GO:0033010) |
1.6 | 4.8 | GO:0044327 | dendritic spine head(GO:0044327) |
1.6 | 9.6 | GO:0032584 | growth cone membrane(GO:0032584) |
1.6 | 6.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.5 | 1.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.5 | 6.1 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.5 | 4.5 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.5 | 7.4 | GO:0033503 | HULC complex(GO:0033503) |
1.5 | 18.9 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.4 | 17.2 | GO:0033391 | chromatoid body(GO:0033391) |
1.4 | 8.5 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
1.4 | 12.7 | GO:0000124 | SAGA complex(GO:0000124) |
1.4 | 18.2 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.4 | 2.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.4 | 4.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
1.3 | 4.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.3 | 6.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
1.3 | 164.7 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.3 | 5.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
1.3 | 2.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
1.3 | 1.3 | GO:0097441 | basilar dendrite(GO:0097441) |
1.2 | 3.7 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
1.2 | 96.1 | GO:0043204 | perikaryon(GO:0043204) |
1.2 | 11.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
1.2 | 3.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.2 | 5.9 | GO:0070695 | FHF complex(GO:0070695) |
1.2 | 2.4 | GO:0071203 | WASH complex(GO:0071203) |
1.2 | 4.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.1 | 9.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.1 | 6.8 | GO:0030008 | TRAPP complex(GO:0030008) |
1.1 | 5.7 | GO:0044292 | dendrite terminus(GO:0044292) |
1.1 | 3.4 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.1 | 4.5 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.1 | 3.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
1.1 | 4.4 | GO:0033269 | internode region of axon(GO:0033269) |
1.1 | 1.1 | GO:0043219 | lateral loop(GO:0043219) |
1.1 | 19.3 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.1 | 9.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.1 | 5.3 | GO:0016589 | NURF complex(GO:0016589) |
1.1 | 4.2 | GO:0030478 | actin cap(GO:0030478) |
1.0 | 7.3 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
1.0 | 5.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
1.0 | 6.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
1.0 | 5.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
1.0 | 11.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
1.0 | 39.7 | GO:0043197 | dendritic spine(GO:0043197) |
1.0 | 1.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
1.0 | 1.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.9 | 2.8 | GO:0031417 | NatC complex(GO:0031417) |
0.9 | 0.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.9 | 5.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.9 | 4.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.9 | 1.8 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.9 | 3.6 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.9 | 4.5 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.9 | 3.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.9 | 3.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.9 | 119.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.9 | 2.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.9 | 0.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.9 | 0.9 | GO:0044308 | axonal spine(GO:0044308) |
0.9 | 3.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.8 | 2.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.8 | 2.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.8 | 10.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.8 | 12.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 50.5 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.8 | 4.8 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.8 | 8.7 | GO:0042555 | MCM complex(GO:0042555) |
0.8 | 1.6 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.8 | 2.3 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 5.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.8 | 7.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.8 | 4.6 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.8 | 10.7 | GO:0000800 | lateral element(GO:0000800) |
0.8 | 31.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.8 | 1.5 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.7 | 2.2 | GO:0033268 | node of Ranvier(GO:0033268) |
0.7 | 21.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.7 | 2.9 | GO:0032021 | NELF complex(GO:0032021) |
0.7 | 6.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 6.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.7 | 1.4 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.7 | 2.8 | GO:0070876 | SOSS complex(GO:0070876) |
0.7 | 42.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.7 | 44.8 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.7 | 4.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.7 | 2.1 | GO:0036396 | MIS complex(GO:0036396) |
0.7 | 2.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 0.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.7 | 3.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.6 | 3.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.6 | 1.3 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.6 | 1.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 3.2 | GO:0097255 | R2TP complex(GO:0097255) |
0.6 | 2.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.6 | 1.9 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 5.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.6 | 1.9 | GO:0098793 | presynapse(GO:0098793) |
0.6 | 8.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.6 | 4.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.6 | 8.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.6 | 4.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.6 | 1.2 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.6 | 4.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.6 | 1.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.6 | 2.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.6 | 1.7 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.5 | 2.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.5 | 3.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.5 | 1.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.5 | 1.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.5 | 1.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.5 | 2.0 | GO:0098536 | deuterosome(GO:0098536) |
0.5 | 1.5 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.5 | 3.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.5 | 1.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.5 | 3.8 | GO:0060091 | kinocilium(GO:0060091) |
0.5 | 1.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.5 | 1.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.5 | 2.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.5 | 1.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.5 | 2.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.5 | 1.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 4.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.4 | 11.7 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.4 | 1.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 1.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 1.3 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 1.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.4 | 3.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 0.4 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.4 | 5.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.4 | 1.3 | GO:0071546 | pi-body(GO:0071546) |
0.4 | 19.6 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.4 | 5.8 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 59.3 | GO:0030424 | axon(GO:0030424) |
0.4 | 0.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.4 | 22.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.4 | 2.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.4 | 11.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.4 | 2.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.4 | 1.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.4 | 2.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.4 | 4.0 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 3.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.4 | 13.5 | GO:0030426 | growth cone(GO:0030426) |
0.3 | 1.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 15.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 2.7 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 3.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.3 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 2.1 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 3.7 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 1.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.3 | 7.5 | GO:0032587 | ruffle membrane(GO:0032587) |
0.3 | 0.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 0.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.3 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 6.4 | GO:0032040 | small-subunit processome(GO:0032040) |
0.3 | 13.4 | GO:0098794 | postsynapse(GO:0098794) |
0.3 | 0.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 0.3 | GO:0035838 | growing cell tip(GO:0035838) |
0.3 | 0.9 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 0.6 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 0.5 | GO:0034705 | potassium channel complex(GO:0034705) |
0.3 | 9.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.3 | 24.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.3 | 0.3 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.8 | GO:0034706 | sodium channel complex(GO:0034706) |
0.3 | 1.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 5.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 0.2 | GO:0032009 | early phagosome(GO:0032009) |
0.2 | 1.5 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 2.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 8.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.9 | GO:0000938 | GARP complex(GO:0000938) |
0.2 | 0.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 0.6 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 1.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.2 | 3.3 | GO:0097228 | sperm principal piece(GO:0097228) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 0.2 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.2 | 1.6 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 15.8 | GO:0045202 | synapse(GO:0045202) |
0.2 | 0.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 7.3 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 3.4 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 5.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 1.0 | GO:0032426 | stereocilium tip(GO:0032426) |
0.2 | 0.8 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 747.1 | GO:0016021 | integral component of membrane(GO:0016021) |
0.2 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.2 | GO:0005767 | secondary lysosome(GO:0005767) |
0.2 | 1.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.4 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 0.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 10.2 | GO:0043209 | myelin sheath(GO:0043209) |
0.1 | 1.0 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 4.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 0.1 | GO:0019867 | outer membrane(GO:0019867) organelle outer membrane(GO:0031968) |
0.1 | 0.9 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 3.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.5 | GO:0042611 | MHC protein complex(GO:0042611) |
0.1 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.5 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.6 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.4 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.1 | 0.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 0.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 1.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.1 | 1.2 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 1.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.1 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.1 | 0.1 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 0.2 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 6.8 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.0 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.0 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.0 | GO:0031528 | microvillus membrane(GO:0031528) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
16.6 | 66.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
10.8 | 54.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
10.2 | 50.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
7.6 | 22.7 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
7.3 | 36.5 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
7.3 | 29.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
7.3 | 21.8 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
6.9 | 13.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
6.9 | 61.9 | GO:0016595 | glutamate binding(GO:0016595) |
6.4 | 50.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
6.3 | 18.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
6.3 | 18.8 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
5.9 | 17.7 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
5.9 | 29.3 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
5.5 | 16.6 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
5.3 | 21.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
5.2 | 15.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
5.1 | 15.4 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
5.0 | 15.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
5.0 | 14.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
4.9 | 14.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
4.8 | 23.9 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
4.7 | 18.6 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
4.6 | 32.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
4.2 | 33.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
3.8 | 3.8 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
3.7 | 14.7 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
3.7 | 11.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
3.7 | 11.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
3.7 | 14.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
3.5 | 13.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.5 | 10.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
3.4 | 10.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
3.3 | 16.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
3.3 | 36.6 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
3.3 | 13.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
3.2 | 29.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
3.2 | 9.6 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
3.0 | 12.1 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
3.0 | 9.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
2.8 | 8.3 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.7 | 2.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
2.7 | 37.3 | GO:0031402 | sodium ion binding(GO:0031402) |
2.6 | 50.0 | GO:0016917 | GABA receptor activity(GO:0016917) |
2.6 | 10.4 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
2.6 | 15.5 | GO:0048495 | Roundabout binding(GO:0048495) |
2.5 | 12.7 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
2.5 | 12.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
2.5 | 7.5 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
2.5 | 14.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
2.3 | 16.3 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
2.3 | 9.3 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
2.3 | 4.5 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
2.2 | 4.5 | GO:0043398 | HLH domain binding(GO:0043398) |
2.2 | 13.3 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
2.2 | 11.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
2.2 | 17.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
2.2 | 10.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
2.1 | 64.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
2.1 | 21.5 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.1 | 6.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
2.0 | 69.6 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
2.0 | 10.1 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
2.0 | 10.0 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
2.0 | 13.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.9 | 3.9 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
1.9 | 5.8 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
1.9 | 49.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.9 | 7.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.9 | 22.7 | GO:0070402 | NADPH binding(GO:0070402) |
1.9 | 5.6 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
1.8 | 20.3 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
1.8 | 5.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.8 | 5.5 | GO:0035939 | microsatellite binding(GO:0035939) |
1.8 | 5.5 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.8 | 1.8 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
1.8 | 25.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.8 | 5.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.8 | 9.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
1.8 | 1.8 | GO:0045340 | mercury ion binding(GO:0045340) |
1.8 | 12.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
1.8 | 3.6 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
1.8 | 5.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
1.7 | 5.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.7 | 30.9 | GO:0005112 | Notch binding(GO:0005112) |
1.7 | 3.4 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.7 | 1.7 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
1.7 | 10.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
1.7 | 13.4 | GO:0038191 | neuropilin binding(GO:0038191) |
1.7 | 5.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
1.6 | 4.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
1.6 | 21.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.6 | 21.1 | GO:0015643 | toxic substance binding(GO:0015643) |
1.6 | 13.0 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
1.6 | 6.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
1.6 | 3.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
1.6 | 3.2 | GO:0097001 | ceramide binding(GO:0097001) |
1.6 | 6.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
1.6 | 4.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.6 | 71.8 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
1.6 | 14.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
1.6 | 4.7 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
1.6 | 3.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
1.6 | 3.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
1.5 | 15.5 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
1.5 | 4.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.5 | 24.5 | GO:0008373 | sialyltransferase activity(GO:0008373) |
1.5 | 4.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
1.5 | 4.6 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.5 | 15.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
1.5 | 4.5 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.5 | 4.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.5 | 4.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.5 | 21.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.5 | 11.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
1.4 | 13.0 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
1.4 | 4.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.4 | 18.6 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.4 | 4.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
1.4 | 8.5 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.4 | 11.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
1.4 | 29.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.4 | 5.5 | GO:1990254 | keratin filament binding(GO:1990254) |
1.4 | 4.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
1.4 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.4 | 1.4 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.4 | 6.8 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
1.4 | 9.5 | GO:0033691 | sialic acid binding(GO:0033691) |
1.4 | 5.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.3 | 4.0 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
1.3 | 5.3 | GO:0019808 | polyamine binding(GO:0019808) |
1.3 | 10.6 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.3 | 39.4 | GO:0035254 | glutamate receptor binding(GO:0035254) |
1.3 | 11.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
1.3 | 9.1 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.3 | 3.9 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.3 | 16.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
1.3 | 1.3 | GO:0003680 | AT DNA binding(GO:0003680) |
1.3 | 3.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
1.3 | 6.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
1.2 | 3.7 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.2 | 5.0 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.2 | 2.5 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.2 | 4.9 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.2 | 3.7 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
1.2 | 2.4 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
1.2 | 4.8 | GO:0019003 | GDP binding(GO:0019003) |
1.2 | 3.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
1.2 | 6.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.2 | 3.6 | GO:0051373 | FATZ binding(GO:0051373) |
1.2 | 15.4 | GO:0031005 | filamin binding(GO:0031005) |
1.2 | 1.2 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.1 | 3.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.1 | 1.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.1 | 18.1 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.1 | 4.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
1.1 | 9.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
1.1 | 5.5 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.1 | 5.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.1 | 13.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
1.1 | 8.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.1 | 4.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
1.1 | 11.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
1.1 | 3.2 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.1 | 1.1 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
1.1 | 12.8 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.1 | 12.8 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
1.1 | 14.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
1.1 | 2.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 7.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
1.0 | 6.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.0 | 6.2 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
1.0 | 4.1 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
1.0 | 4.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
1.0 | 16.4 | GO:0003785 | actin monomer binding(GO:0003785) |
1.0 | 2.1 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
1.0 | 3.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.0 | 7.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.0 | 8.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
1.0 | 5.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.0 | 5.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
1.0 | 5.0 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
1.0 | 3.0 | GO:0045545 | syndecan binding(GO:0045545) |
1.0 | 3.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
1.0 | 4.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.0 | 8.9 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.0 | 11.9 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
1.0 | 51.2 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
1.0 | 3.9 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 9.7 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
1.0 | 9.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.0 | 7.7 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.9 | 5.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.9 | 2.8 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.9 | 4.6 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.9 | 1.8 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.9 | 4.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.9 | 24.6 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.9 | 2.7 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.9 | 9.1 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.9 | 2.7 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.9 | 37.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.9 | 37.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.9 | 0.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.9 | 20.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.9 | 1.7 | GO:0032356 | oxidized DNA binding(GO:0032356) oxidized purine DNA binding(GO:0032357) |
0.9 | 25.2 | GO:0070888 | E-box binding(GO:0070888) |
0.9 | 2.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.9 | 10.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.9 | 2.6 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.9 | 11.9 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.8 | 2.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.8 | 15.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.8 | 2.5 | GO:0034816 | fluorene oxygenase activity(GO:0018585) mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.8 | 17.8 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.8 | 2.5 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.8 | 20.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.8 | 16.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.8 | 13.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.8 | 5.8 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.8 | 4.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.8 | 9.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.8 | 6.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.8 | 12.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.8 | 1.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.8 | 9.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.8 | 1.6 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 13.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.8 | 2.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.8 | 3.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.8 | 5.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.8 | 4.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.8 | 3.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.8 | 2.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.8 | 10.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.8 | 16.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.8 | 8.4 | GO:0070635 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
0.8 | 0.8 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.8 | 2.3 | GO:0016151 | nickel cation binding(GO:0016151) |
0.8 | 3.0 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.8 | 3.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.8 | 3.8 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.7 | 40.4 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.7 | 4.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.7 | 2.2 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.7 | 3.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.7 | 2.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.7 | 10.3 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.7 | 16.8 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.7 | 3.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.7 | 1.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.7 | 0.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.7 | 7.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 2.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.7 | 2.1 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.7 | 9.1 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.7 | 6.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.7 | 1.4 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.7 | 2.8 | GO:0050693 | LBD domain binding(GO:0050693) |
0.7 | 2.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.7 | 5.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.7 | 3.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.7 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.7 | 4.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.7 | 7.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 0.7 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.7 | 5.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.7 | 2.0 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.7 | 8.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.7 | 2.6 | GO:0030955 | potassium ion binding(GO:0030955) |
0.7 | 10.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.6 | 53.4 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.6 | 5.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 3.8 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.6 | 28.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.6 | 3.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 14.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.6 | 10.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.6 | 3.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 3.7 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
0.6 | 1.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 1.8 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 7.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.6 | 3.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.6 | 1.8 | GO:2001069 | glycogen binding(GO:2001069) |
0.6 | 1.2 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.6 | 2.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 2.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.6 | 3.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.6 | 6.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.6 | 5.7 | GO:0005522 | profilin binding(GO:0005522) |
0.6 | 4.5 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.6 | 3.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.6 | 10.0 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.6 | 20.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.6 | 14.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.5 | 6.0 | GO:0070403 | NAD+ binding(GO:0070403) |
0.5 | 2.2 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 1.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.5 | 1.1 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 3.7 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.5 | 1.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 2.1 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 4.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.5 | 0.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.5 | 2.6 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.5 | 7.7 | GO:0030276 | clathrin binding(GO:0030276) |
0.5 | 7.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 3.5 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.5 | 2.0 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 1.5 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 1.0 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.5 | 1.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 3.0 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 1.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.5 | 2.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.5 | 8.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 2.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 5.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 5.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.5 | 1.4 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.5 | 0.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.5 | 10.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 1.4 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.5 | 0.5 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.5 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.5 | 1.4 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.5 | 2.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.4 | GO:0035473 | lipase binding(GO:0035473) |
0.5 | 2.8 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.5 | 1.4 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.4 | 0.9 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 2.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.4 | 9.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.4 | 1.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.4 | 3.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.4 | 1.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.4 | 4.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.4 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 0.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 6.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 0.4 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.4 | 5.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.4 | 8.3 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 1.2 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.4 | 18.6 | GO:0017022 | myosin binding(GO:0017022) |
0.4 | 1.7 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.4 | 0.4 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.4 | 3.6 | GO:0052859 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.4 | 4.0 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.4 | 3.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.4 | 1.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.4 | 1.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 0.4 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.4 | 0.7 | GO:0002054 | nucleobase binding(GO:0002054) |
0.4 | 1.1 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 6.5 | GO:0005262 | calcium channel activity(GO:0005262) |
0.4 | 1.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 1.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.3 | 1.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 1.4 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.3 | 0.7 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.3 | 0.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.3 | 3.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.3 | 4.3 | GO:0030275 | LRR domain binding(GO:0030275) |
0.3 | 3.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.3 | 1.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 1.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 1.3 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.3 | 2.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.3 | 1.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 1.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.3 | 0.9 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 1.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 3.9 | GO:0005272 | sodium channel activity(GO:0005272) |
0.3 | 5.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.3 | 2.0 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.3 | 0.9 | GO:0032052 | bile acid binding(GO:0032052) |
0.3 | 0.3 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 0.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.3 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 0.6 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.3 | 1.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 1.6 | GO:0010181 | FMN binding(GO:0010181) |
0.3 | 2.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.3 | 0.8 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.3 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 1.0 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 1.8 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.3 | 1.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.3 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 0.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 1.0 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 5.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 2.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 1.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.2 | 9.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 3.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) acetylcholine receptor activity(GO:0015464) |
0.2 | 6.4 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.2 | 3.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 5.1 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 1.4 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 4.4 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 2.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 1.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 1.6 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.9 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.2 | 0.4 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.2 | 0.8 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.2 | 0.6 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 0.8 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.2 | 0.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 1.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 0.8 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 7.2 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 0.4 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.2 | 0.6 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.2 | 1.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 1.2 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.2 | 0.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.2 | 1.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.2 | 3.4 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 18.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 2.2 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.2 | 2.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.5 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.2 | 1.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.2 | 0.2 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.2 | 1.9 | GO:0005267 | potassium channel activity(GO:0005267) |
0.2 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 3.5 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.2 | 3.3 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.2 | 5.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.2 | 0.3 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 0.1 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.9 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 5.0 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.1 | 0.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 0.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.1 | 4.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.1 | 0.3 | GO:0034809 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.7 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 2.1 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.1 | 0.3 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.1 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 2.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 1.0 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 2.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.9 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.2 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.1 | 0.4 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.9 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 0.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.4 | GO:0004953 | icosanoid receptor activity(GO:0004953) |
0.1 | 1.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 0.2 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 2.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.3 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.1 | 0.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.9 | GO:0048038 | quinone binding(GO:0048038) |
0.1 | 0.4 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
0.1 | 0.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.1 | 16.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 5.3 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 1.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.7 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 18.3 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 24.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.2 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.1 | 0.7 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 1.0 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 0.4 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 0.2 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 4.2 | GO:0005179 | hormone activity(GO:0005179) |
0.1 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.0 | 1.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.2 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.0 | 0.1 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
0.0 | 0.0 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 15.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.0 | 0.1 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.0 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 0.2 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.0 | 0.4 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.0 | 0.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.0 | 3.3 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 1.9 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 15.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
0.0 | 0.0 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.6 | 7.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
1.7 | 36.2 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
1.6 | 96.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
1.5 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
1.5 | 1.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.3 | 2.6 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
1.3 | 20.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
1.2 | 7.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.1 | 18.1 | PID EPHB FWD PATHWAY | EPHB forward signaling |
1.0 | 5.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.9 | 1.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.9 | 16.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.9 | 3.5 | PID EPO PATHWAY | EPO signaling pathway |
0.9 | 13.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.9 | 12.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.8 | 11.9 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.8 | 10.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.8 | 13.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.7 | 0.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.7 | 6.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.7 | 12.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.7 | 3.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.7 | 3.3 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 5.7 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.6 | 4.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 2.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.5 | 2.5 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 17.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 9.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.5 | 1.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.5 | 18.2 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.5 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 0.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.4 | 0.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.4 | 2.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.4 | 4.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 66.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 4.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.4 | 7.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 4.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.3 | 7.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 4.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 4.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 3.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.3 | 5.3 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.3 | 6.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.3 | 7.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.3 | 2.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 77.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.3 | 3.6 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 1.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.3 | 3.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 1.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 2.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.2 | 0.4 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.2 | 5.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 1.4 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 0.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 4.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.8 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 0.1 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 0.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 2.1 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 0.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 1.4 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 1.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.1 | 1.0 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 1.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 9.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.1 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 0.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 0.9 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 6.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.1 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 0.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.4 | 96.6 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
5.6 | 33.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
4.3 | 51.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.7 | 30.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.3 | 45.9 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
3.1 | 43.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.9 | 61.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.7 | 29.8 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.7 | 24.1 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
2.6 | 21.1 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
2.6 | 43.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
2.5 | 17.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
2.4 | 19.3 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
2.1 | 32.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.0 | 28.1 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.0 | 15.7 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
1.9 | 5.8 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
1.9 | 78.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
1.9 | 44.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
1.9 | 3.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
1.8 | 25.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.8 | 3.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
1.8 | 19.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
1.6 | 40.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
1.5 | 26.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.5 | 1.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
1.4 | 14.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
1.4 | 25.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
1.3 | 14.8 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.3 | 11.5 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.3 | 14.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
1.2 | 2.5 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.2 | 9.8 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
1.2 | 15.6 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
1.2 | 21.9 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.1 | 53.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
1.1 | 4.4 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
1.1 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
1.1 | 37.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.1 | 20.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.0 | 5.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.0 | 9.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
1.0 | 4.8 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.0 | 12.5 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.0 | 3.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.9 | 17.7 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.9 | 12.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.9 | 29.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.9 | 11.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.9 | 21.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.9 | 2.7 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.9 | 13.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.8 | 16.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.8 | 13.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.8 | 15.1 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.8 | 49.3 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.8 | 35.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.8 | 13.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 1.6 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.8 | 8.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.8 | 9.3 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.8 | 12.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.8 | 0.8 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.7 | 3.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.7 | 3.6 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.7 | 4.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.7 | 4.7 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.7 | 7.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 4.4 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 5.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.6 | 1.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.6 | 37.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.6 | 5.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.6 | 0.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.5 | 0.5 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.5 | 9.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.5 | 43.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.5 | 10.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 7.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.5 | 32.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.5 | 1.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 11.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.5 | 4.9 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.5 | 6.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.5 | 10.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.4 | 0.9 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.4 | 4.9 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.4 | 1.7 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 7.2 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.4 | 3.4 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.4 | 1.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.4 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 1.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 4.9 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.4 | 4.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 5.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.4 | 0.4 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.4 | 4.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 1.9 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.4 | 4.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.4 | 12.3 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.4 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 1.8 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.4 | 3.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 6.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.3 | 4.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.3 | 14.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 0.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.3 | 7.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 6.2 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.3 | 2.4 | REACTOME OPSINS | Genes involved in Opsins |
0.3 | 2.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 2.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.3 | 2.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 3.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 3.5 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.3 | 13.0 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.3 | 7.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.3 | 1.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 3.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.2 | 36.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.2 | 16.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 0.6 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.2 | 8.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 8.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.2 | 1.0 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.2 | 6.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 3.3 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 4.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 1.0 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 2.5 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.5 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.1 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.1 | 0.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.2 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 0.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.6 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.0 | 0.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.1 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |